[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370340-105":59,"doc-detail-370340-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","haploinsufficient-phenotypes-promote-selection-of-pten-and-arid1a-deficient-clones-in-human-colon","Haploinsufﬁcient phenotypes promote selection of PTEN and ARID1A-deﬁcient clones in human colon","","Cancer driver mutations are characterized by frequent occurrence in tumors and presumed rarity in normal tissues, but positive selection in normal epithelia can increase their prevalence. This study evaluates cancer-driving potential by quantifying age-related mutational burdens in normal human colonic epithelium from FFPE samples (N=181). Positive selection of PTEN and ARID1A variants associates with monoallelic gene loss confirmed by CRISPR/Cas9, alters downstream effectors, and supports potency estimation via relative representation versus cancers. Immune exclusion is observed in ARID1A-deficient clones within histologically normal tissue, linking haploinsufficiency, somatic mosaicism, and cancer initiation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/haploinsufficient-phenotypes-promote-selection-of-pten-and-arid1a-deficient-clones-in-human-colon/370340/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/haploinsufficient-phenotypes-promote-selection-of-pten-and-arid1a-deficient-clones-in-human-colon/370340.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the study assess the true cancer-driving potential of PTEN and ARID1A variants?","Question",{"text":112,"@type":113},"It quantifies age-related mutational burdens in normal human colonic epithelium and compares their representation with colorectal cancers to estimate relative driver potency.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What experimental evidence links variant selection to PTEN and ARID1A deficiency?",{"text":117,"@type":113},"Immunodetection and CRISPR/Cas9 mutagenesis show positive selection associates with monoallelic gene loss and changes in downstream effectors.",{"name":119,"@type":110,"acceptedAnswer":120},"What tumor-like hallmark is observed in normal tissue in the context of ARID1A-deficient clones?",{"text":121,"@type":113},"Immune exclusion is observed within ARID1A-deficient clones in histologically normal epithelial tissue.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370340,1790409189,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nHaploinsufﬁcient phenotypes promote selection of PTEN and ARID1A-deﬁcient clones in human colon  \nNefeli Skoufou-Papoutsaki 1,2, Sam Adler1, Shenay Mehmed1, Claire Tume1, Cora Olpe1, Edward Morrissey3, Richard Kemp 1, Anne-Claire Girard1, Elisa B Moutin1,  \nChandra Sekhar Reddy Chilamakuri1, Jodi L Miller 1, Cecilia Lindskog 4, Fabian Werle1, Kate Marks5, Francesca Perrone2, Matthias Zilbauer2, David S Tourigny6 & Douglas J Winton 1,2 ✉  \nAbstract  \nCancer driver mutations are deﬁned by their high prevalence in cancers and presumed rarity in normal tissues. However, recent studies show that positive selection in normal epithelia can increase the prevalence of some cancer drivers. To determine their true cancerdriving potential, it is essential to evaluate how frequent these mutations are in normal tissues and what are their phenotypes. Here, we explore the bioavailability of somatic variants by quantifying agerelated mutational burdens in normal human colonic epithelium using immunodetection in FFPE samples (N = 181 patients). Positive selection of variants of tumour suppressor genes PTEN and ARID1A associates with monoallelic gene loss as conﬁrmed by CRISPR/Cas9 mutagenesis and changes in their downstream effectors. Comparison of the mutational burden in normal tissue and colorectal cancers allows quantiﬁcation of cancer driver potency based on relative representation. Additionally, immune exclusion, a cancer hallmark feature, is observed within ARID1A-deﬁcient clones in histologically normal tissue. The behaviour resulting from haploinsufﬁciency of PTEN and ARID1A demonstrates how somatic mosaicism of tumour suppressors arises and can predispose to cancer initiation.  \nKeywords Haploinsufﬁcency; Clone Dynamics; Normal Tissue; PTEN; ARID1A  \nSubject Categories Cancer; Genetics, Gene Therapy & Genetic Disease; Signal Transduction  \n[https://doi.org/10.1038/s44319-025-00373-0](https://doi.org/10.1038/s44319-025-00373-0)  \nReceived 22 October 2024; Revised 8 January 2025; Accepted 10 January 2025  \nPublished online: 7 February 2025  \nIntroduction  \nThe deﬁnition of a cancer driver gene largely arises from the high prevalence of its mutated forms in cancer compared to their presumptive low frequency in normal epithelium. However, recent  \nstudies have shown that the prevalence of somatic mutations in normal epithelia can be highly skewed due to positive selection resulting in substantial clonal expansions. Importantly, selection acting to elevate mutational burden in normal tissue is a poor predictor of cancer driver activity, with gene mutations being strongly selected in host tissue but almost absent in cancers, such as NOTCH1 in the oesophagus (Abby et al, 2023; Martincorena et al, 2018), and vice versa. To better relate mutation prevalence in cancers to a role in cancer causation, we need to understand the extent to which somatic variants are bioavailable at the time of transformation, and could be instead acting as passengers in the process. Currently, there is a lack of conceptual approaches to enable such analyses, largely because of a lack of data about variant selection in normal tissues.  \nWe have previously been able to quantify the processes that generate age-related mutational burden in normal human FFPE colonic epithelium by visualising somatic variants of a small number of X-linked genes in situ. Here, we sought to extend the approach to include autosomal genes that were tumour suppressors for colorectal cancer (CRC) . Notably, positive selection biases were found to be associated with PTEN and ARID1A-deﬁciency, increasing their overall mutational burden. Immunodetection and CRISPR/Cas9 mutagenesis related such phenotypes to the loss of a single allele, suggesting a haploinsufﬁ cient role for these tumour suppressors in a pre-neoplastic context. Knowledge of selection biases and somatic variant burden in the normal colon allows a quantitative contribution of of passenger effects for cancer drivers based o","cbCaitwg1FDMP4NF","https://ap.wps.com/l/cbCaitwg1FDMP4NF","pdf",10050761,21,"English","# Introduction\n# Results\n## Meta-analysis of truncal CRC drivers identifies genes involved in cancer initiation","[{\"question\":\"How does the study assess the true cancer-driving potential of PTEN and ARID1A variants?\",\"answer\":\"It quantifies age-related mutational burdens in normal human colonic epithelium and compares their representation with colorectal cancers to estimate relative driver potency.\"},{\"question\":\"What experimental evidence links variant selection to PTEN and ARID1A deficiency?\",\"answer\":\"Immunodetection and CRISPR/Cas9 mutagenesis show positive selection associates with monoallelic gene loss and changes in downstream effectors.\"},{\"question\":\"What tumor-like hallmark is observed in normal tissue in the context of ARID1A-deficient clones?\",\"answer\":\"Immune exclusion is observed within ARID1A-deficient clones in histologically normal epithelial tissue.\"}]","Haploinsufﬁcient phenotypes promote selection of PTEN and ARID1A-deﬁcient clones in human colon | PDF",1790188116,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7b5d7a49345acb8330b19459388ad28.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a4affc245bcc0f46f245de8c2ec5ce4.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/916afc11b251cbecd4def4589245074e.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7879f5b30b7698c619f05355b5c80f72.webp",980,1301]